Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Détails

Ressource 1Télécharger: serval:BIB_C6FF10774C6D.P001 (229.80 [Ko])
Etat: Public
Version: de l'auteur
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_C6FF10774C6D
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Périodique
Annals of Oncology
Auteur(s)
Wasserfallen  J. B., Rollier  P., Leyvraz  S., Perey  L.
ISSN
0923-7534 (Print)
Statut éditorial
Publié
Date de publication
02/1999
Volume
10
Numéro
2
Pages
243-4
Notes
Comparative Study
Letter --- Old month value: Feb
Mots-clé
Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma, Small Cell/*drug therapy Cisplatin/administration & dosage Doxorubicin/administration & dosage Etoposide/administration & dosage Health Care Costs *Hematopoietic Stem Cell Transplantation Humans Ifosfamide/administration & dosage Lung Neoplasms/*drug therapy Middle Aged
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 9:31
Dernière modification de la notice
25/09/2019 7:10
Données d'usage